Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jeffrey Geitz (NPI 1124246855)

Field	Value
Entity Type	Individual
Organization	Jeffrey Geitz
Address	511 S Santa Fe Ave
City	Salina
State	KS
ZIP	67401
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 20, 2007

Payer Source	Total Paid
Medicare	$3.3M
Medicaid	$0

Key Findings

This provider is a Hematology & Oncology physician in SALINA, KS with an NPI enumerated 2007-04-20 (~19 years ago). Lifetime Medicare revenue on file is $3.3M and there is no Medicaid billing on file, indicating this practice’s reimbursement footprint is effectively single-payer Medicare at present.

Revenue is highly concentrated in a small set of parenteral oncology agents: J9271 ($1.4M, 43.5% of Medicare revenue), J9299 ($1.2M, 35.2% of Medicare revenue), and J0897 ($225.7K, 6.9% of Medicare revenue) together account for 85.6% of this provider’s total Medicare revenue. This degree of concentration implies the majority of Medicare dollars come from a few high-use injectable biologics.

The code mix points to an infusion-focused oncology practice delivering high-volume immunotherapy: J9271 (pembrolizumab) and J9299 (nivolumab) are the top revenue drivers by far, and both are biologic checkpoint inhibitors commonly used in outpatient oncology. The presence of J0897 (denosumab) alongside these immunotherapies further indicates routine supportive bone-directed care for oncology patients.

Procedure and administration codes reinforce an office-based chemotherapy/infusion model: 96413 (948 claims, $88.2K; ranks #97 of 7514 nationally, 99th percentile — extreme outlier) and add-on/continuation codes such as 96417, 96415, and 96411 are reported at notably high national percentiles. G0498 (152 claims, $17.2K; ranks #26 of 896, 97th percentile) for initiation/portable-pump continuation also suggests the practice provides infusion initiation with ongoing community-based pump support.

On competitive standing, this provider ranks unusually high for the two primary oncology drugs: J9299 ranks #16 of 505 providers nationally (97th percentile; notably above typical national volume) and J9271 ranks #86 of 1841 (95th percentile; notably above typical national volume). Those rankings position the clinician as a major national-volume participant for these specific immunotherapies rather than a modest local prescriber.

Outpatient visit volume is also extreme versus peers: 99214 is recorded with 1.8K claims and $165K revenue and is described as an "extreme outlier" (rank #2004 of 479517, 100th percentile). High E/M throughput combined with large infusion volumes implies substantial recurring patient encounters and ongoing management capacity, consistent with a busy oncology clinic.

Multiple ancillary infusion and device-care codes are reported at very high percentiles and likely represent routine operational workstreams: for example, 96411 ranks #23 of 1354 (98th percentile; notably above typical national volume), 96523 ranks #31 of 1643 (98th percentile; notably above typical national volume), and J9190 ranks #35 of 1409 (98th percentile; notably above typical national volume). These patterns underscore frequent IV administrations, venous access maintenance, and supportive medication use in the practice.

The absence of any Medicaid billing on file ("none below") combined with heavy reliance on a few high-revenue biologics creates concentrated payer and product exposure. That structure presents both operational strengths—clear specialization in outpatient immunotherapy infusions—and strategic sensitivity to Medicare reimbursement policy or utilization changes for the named drugs and administration services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

49 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	33,200	$40	$1.4M
J9299	Injection, nivolumab, 1 mg	48,180	$20	$1.2M
J0897	Injection, denosumab, 1 mg	11,880	$20	$225.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,790	$90	$165K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	950	$90	$88.2K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	160	$350	$55.2K
J1437	Injection, ferric derisomaltose, 10 mg	1,500	$20	$24K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community…	150	$110	$17.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	130	$130	$16.9K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	70	$160	$11.5K

Showing 1–10 of 49

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 49 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Jeffrey Geitz — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

49 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	8	20	28,900	$40	$1.1M
J9299	1	10	24,550	$20	$637.2K
J0897	15	180	2,160	$20	$81.5K
J1437	6	10	2,050	$20	$48.2K
J1454	2	10	90	$350	$31.7K
96413	8	80	80	$90	$26.3K
J0641	1	10	71,750	$1	$18.4K
99214	15	4,310	120	$70	$16.4K
99233	753	1,110	100	$90	$16.2K
Q5125	1	10	31,680	$1	$14.4K

Showing 1–10 of 49

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jeffrey Geitz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Jeffrey Geitz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Occk, Inc.	KS	Sports Physical Therapist	$0	$118.5M
Central Kansas Mental Health Center	KS	Community/Behavioral Health Agency	$0	$24.1M
Central Kansas Mental Health Center	KS	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$23M
Saint Francis Community Services, Inc.	KS	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$14.9M
Accessible Home Health Inc.	KS	Home Health Agency	$0	$9.3M
Salina Health Education Foundation	KS	Federally Qualified Health Center (FQHC)	$0	$8.7M
Ckf Addiction Treatment, Inc	KS	Substance Use Disorder Rehabilitation Clinic/Center	$0	$4.6M
Salina Regional Health Center, Inc.	KS	Pediatrics Physician	$0	$4.1M
New Horizon Services, Inc.	KS	Case Management Agency	$0	$3.6M
Salina Regional Health Center, Inc	KS	General Acute Care Hospital	$0	$3.4M

Jeffrey Geitz — Billing Profile & Reimbursement Data

Sign up for Jeffrey Geitz — Billing Profile & Reimbursement Data policy alerts

Jeffrey Geitz — Billing Profile & Reimbursement Data

Sign up for Jeffrey Geitz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References